Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Lymphohistiocytosis, Hemophagocytic 1

Interventions

Emapalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Lymphohistiocytosis, Hemophagocytic × Emapalumab × Clear all
NCT03985423 2023-10-06

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH

Swedish Orphan Biovitrum

Phase 2/3 Terminated
7 enrolled 11 charts
Myeloid

Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡